Ken Research Logo

Global Vascular Closure Device Market

The Global Vascular Closure Device Market, valued at USD 1.6 billion, is projected to grow at 7% CAGR to 2030, fueled by CVD prevalence, advancements in surgical techniques, and demand for outpatient care.

Region:Global

Author(s):Dev

Product Code:KRAA2613

Pages:89

Published On:August 2025

About the Report

Base Year 2024

Global Vascular Closure Device Market Overview

  • The Global Vascular Closure Device Market is valued at approximatelyUSD 1.6 billion, based on a five-year historical analysis. This growth is primarily driven by the increasing prevalence of cardiovascular diseases, advancements in minimally invasive surgical techniques, and the rising demand for effective post-procedural care. The market is further supported by the growing geriatric population, which is more susceptible to vascular conditions, thereby boosting the demand for vascular closure devices. Recent trends highlight the adoption of automated, self-activating closure mechanisms and real-time imaging guidance, enhancing procedural safety and efficiency. Additionally, AI-driven analytics are improving device placement and post-procedural care, optimizing recovery and reducing risks .
  • Key players in this market are predominantly located in North America and Europe, with the United States being a significant contributor due to its advanced healthcare infrastructure and high expenditure on medical devices. North America accounted for approximately 45% of the global market share in the latest analysis, driven by a well-established healthcare system, high rates of cardiovascular disease, and a surge in catheterization procedures. Germany and the UK also lead due to strong emphasis on research and development in medical technologies, fostering innovation in vascular closure devices .
  • In 2023, the U.S. Food and Drug Administration (FDA) issued theMedical Device Safety Action Plan: Protecting Patients, Promoting Public Health (2023), which mandates that all new vascular closure devices undergo rigorous clinical trials to demonstrate their effectiveness and safety prior to approval. The regulation requires manufacturers to submit robust clinical evidence, including randomized controlled trials and post-market surveillance data, ensuring that devices meet stringent safety and efficacy standards before entering the market .
Global Vascular Closure Device Market Size

Global Vascular Closure Device Market Segmentation

By Type:The vascular closure device market is segmented into Passive Vascular Closure Devices, Active Vascular Closure Devices, Suture-Based Closure Devices, Collagen-Based Closure Devices, Clip-Based Closure Devices, and Others.Active Vascular Closure Devicesare gaining traction due to their effectiveness in reducing time to hemostasis and improving patient outcomes. The demand for these devices is driven by their ability to provide reliable closure with minimal complications, making them a preferred choice in clinical settings. Recent innovations include self-activating mechanisms and integration with imaging guidance, further improving procedural safety and efficiency .

Global Vascular Closure Device Market segmentation by Type.

By Access Site:The market is also segmented based on access sites, which include Femoral Access and Radial Access.Femoral Accessremains the dominant approach due to its established efficacy in various procedures, particularly in cardiac interventions. However,Radial Accessis gaining popularity due to its lower complication rates and faster recovery times, appealing to both healthcare providers and patients. The trend toward minimally invasive procedures and outpatient care is further accelerating the adoption of radial access devices .

Global Vascular Closure Device Market segmentation by Access Site.

Global Vascular Closure Device Market Competitive Landscape

The Global Vascular Closure Device Market is characterized by a dynamic mix of regional and international players. Leading participants such as Abbott Laboratories, Terumo Corporation, Medtronic plc, Boston Scientific Corporation, Cardinal Health, Inc., W. L. Gore & Associates, Inc., Teleflex Incorporated, Merit Medical Systems, Inc., Avinger, Inc., Vascular Solutions, Inc. (now part of Teleflex), Biomerics, LLC, Cook Medical Incorporated, Koninklijke Philips N.V. (Philips Healthcare), Stryker Corporation, B. Braun Melsungen AG contribute to innovation, geographic expansion, and service delivery in this space.

Abbott Laboratories

1888

Abbott Park, Illinois, USA

Medtronic plc

1949

Dublin, Ireland

Boston Scientific Corporation

1979

Marlborough, Massachusetts, USA

Teleflex Incorporated

1943

Wayne, Pennsylvania, USA

Stryker Corporation

1941

Kalamazoo, Michigan, USA

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Global Vascular Closure Device Revenue

Revenue Growth Rate (VCD Segment)

Market Share (VCD Segment)

Geographic Presence (Number of Countries/Regions)

R&D Investment as % of Revenue

Global Vascular Closure Device Market Industry Analysis

Growth Drivers

  • Increasing Prevalence of Cardiovascular Diseases:The World Health Organization reported that cardiovascular diseases (CVDs) are responsible for approximately17.9 million deaths annually, accounting for about 32% of all global deaths. In the None region, the prevalence of CVDs is projected to rise by 5% in the future, driven by factors such as aging populations and lifestyle changes. This growing burden of disease is expected to significantly increase the demand for vascular closure devices, as healthcare providers seek effective solutions for managing these conditions.
  • Advancements in Minimally Invasive Surgical Techniques:The shift towards minimally invasive procedures has been transformative in the healthcare sector, with a reported20% increasein such surgeries over the past five years. In None, hospitals are increasingly adopting these techniques due to their benefits, including reduced recovery times and lower complication rates. This trend is expected to drive the demand for vascular closure devices, which are essential for ensuring hemostasis in these procedures, thereby enhancing patient outcomes and operational efficiency.
  • Rising Demand for Outpatient Procedures:The outpatient procedure market is projected to grow significantly, with an estimated30% increasein outpatient surgeries in the future in None. This growth is fueled by the push for cost-effective healthcare solutions and patient preferences for shorter hospital stays. Vascular closure devices play a crucial role in facilitating these outpatient procedures, as they allow for quicker recovery and discharge, thus meeting the rising demand for efficient healthcare delivery models.

Market Challenges

  • High Cost of Vascular Closure Devices:The average cost of vascular closure devices can range fromUSD 500 to USD 1,500 per unit, which poses a significant barrier to widespread adoption, particularly in budget-constrained healthcare systems. In None, hospitals are facing increasing pressure to manage costs while maintaining quality care, leading to hesitance in investing in these devices. This financial challenge can limit access to advanced treatment options for patients, ultimately affecting health outcomes.
  • Stringent Regulatory Approvals:The regulatory landscape for medical devices is becoming increasingly complex, with the FDA and other regulatory bodies imposing rigorous approval processes. In None, the average time for device approval can exceed 12 months, which delays market entry for innovative vascular closure devices. This challenge can hinder manufacturers' ability to respond swiftly to market needs and technological advancements, potentially stifling innovation and growth in the sector.

Global Vascular Closure Device Market Future Outlook

The future of the vascular closure device market in None is poised for significant transformation, driven by technological advancements and evolving healthcare paradigms. As patient-centric care becomes a priority, the integration of digital health technologies will enhance monitoring and management of vascular procedures. Additionally, the increasing focus on cost-effective healthcare solutions will likely spur innovation in device design and functionality, ensuring that vascular closure devices remain integral to modern surgical practices and outpatient care strategies.

Market Opportunities

  • Expansion in Emerging Markets:Emerging markets in None present substantial growth opportunities for vascular closure device manufacturers. With rising healthcare expenditures projected to reachUSD 200 billionin the future, companies can capitalize on the increasing demand for advanced medical technologies, particularly in regions with growing populations and improving healthcare infrastructure.
  • Development of Next-Generation Devices:The ongoing innovation in vascular closure devices, including bioresorbable materials and smart technologies, offers significant market potential. As healthcare providers seek improved patient outcomes, the introduction of next-generation devices that enhance safety and efficacy can capture a larger market share, particularly in None, where demand for advanced solutions is on the rise.

Scope of the Report

SegmentSub-Segments
By Type

Passive Vascular Closure Devices

Active Vascular Closure Devices

Suture-Based Closure Devices

Collagen-Based Closure Devices

Clip-Based Closure Devices

Others

By Access Site

Femoral Access

Radial Access

By End-User

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others

By Application

Cardiac Procedures

Peripheral Procedures

Endovascular Procedures

Neurovascular Procedures

Others

By Distribution Channel

Direct Sales

Distributors

Online Sales

Others

By Region

North America

Europe

Asia-Pacific

Latin America

Middle East & Africa

By Price Range

Low Price Range

Mid Price Range

High Price Range

By Regulatory Approval Status

FDA Approved

CE Marked

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., U.S. Food and Drug Administration, European Medicines Agency)

Manufacturers and Producers

Distributors and Retailers

Healthcare Providers and Hospitals

Medical Device Regulatory Consultants

Industry Associations (e.g., Medical Device Manufacturers Association)

Financial Institutions and Investment Banks

Players Mentioned in the Report:

Abbott Laboratories

Terumo Corporation

Medtronic plc

Boston Scientific Corporation

Cardinal Health, Inc.

W. L. Gore & Associates, Inc.

Teleflex Incorporated

Merit Medical Systems, Inc.

Avinger, Inc.

Vascular Solutions, Inc. (now part of Teleflex)

Biomerics, LLC

Cook Medical Incorporated

Koninklijke Philips N.V. (Philips Healthcare)

Stryker Corporation

B. Braun Melsungen AG

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Global Vascular Closure Device Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Global Vascular Closure Device Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Global Vascular Closure Device Market Analysis

3.1 Growth Drivers

3.1.1 Increasing prevalence of cardiovascular diseases
3.1.2 Advancements in minimally invasive surgical techniques
3.1.3 Rising demand for outpatient procedures
3.1.4 Technological innovations in vascular closure devices

3.2 Market Challenges

3.2.1 High cost of vascular closure devices
3.2.2 Stringent regulatory approvals
3.2.3 Limited awareness among healthcare professionals
3.2.4 Competition from alternative hemostatic methods

3.3 Market Opportunities

3.3.1 Expansion in emerging markets
3.3.2 Development of next-generation devices
3.3.3 Strategic partnerships and collaborations
3.3.4 Increasing investment in healthcare infrastructure

3.4 Market Trends

3.4.1 Shift towards patient-centric care
3.4.2 Growing adoption of digital health technologies
3.4.3 Focus on cost-effective healthcare solutions
3.4.4 Rise in telemedicine and remote monitoring

3.5 Government Regulation

3.5.1 FDA guidelines for vascular closure devices
3.5.2 CE marking requirements in Europe
3.5.3 Reimbursement policies for vascular procedures
3.5.4 Safety and efficacy standards for medical devices

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Global Vascular Closure Device Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Global Vascular Closure Device Market Segmentation

8.1 By Type

8.1.1 Passive Vascular Closure Devices
8.1.2 Active Vascular Closure Devices
8.1.3 Suture-Based Closure Devices
8.1.4 Collagen-Based Closure Devices
8.1.5 Clip-Based Closure Devices
8.1.6 Others

8.2 By Access Site

8.2.1 Femoral Access
8.2.2 Radial Access

8.3 By End-User

8.3.1 Hospitals
8.3.2 Ambulatory Surgical Centers
8.3.3 Specialty Clinics
8.3.4 Others

8.4 By Application

8.4.1 Cardiac Procedures
8.4.2 Peripheral Procedures
8.4.3 Endovascular Procedures
8.4.4 Neurovascular Procedures
8.4.5 Others

8.5 By Distribution Channel

8.5.1 Direct Sales
8.5.2 Distributors
8.5.3 Online Sales
8.5.4 Others

8.6 By Region

8.6.1 North America
8.6.2 Europe
8.6.3 Asia-Pacific
8.6.4 Latin America
8.6.5 Middle East & Africa

8.7 By Price Range

8.7.1 Low Price Range
8.7.2 Mid Price Range
8.7.3 High Price Range

8.8 By Regulatory Approval Status

8.8.1 FDA Approved
8.8.2 CE Marked
8.8.3 Others

9. Global Vascular Closure Device Market Competitive Analysis

9.1 Market Share of Key Players

9.2 KPIs for Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Global Vascular Closure Device Revenue
9.2.4 Revenue Growth Rate (VCD Segment)
9.2.5 Market Share (VCD Segment)
9.2.6 Geographic Presence (Number of Countries/Regions)
9.2.7 R&D Investment as % of Revenue
9.2.8 Number of Patents/Innovations (VCD-related)
9.2.9 Regulatory Approvals (FDA, CE, etc.)
9.2.10 Distribution Network Strength
9.2.11 Product Portfolio Breadth (VCD Types)
9.2.12 Customer Satisfaction Score
9.2.13 Key Strategic Partnerships/Collaborations

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Abbott Laboratories
9.5.2 Terumo Corporation
9.5.3 Medtronic plc
9.5.4 Boston Scientific Corporation
9.5.5 Cardinal Health, Inc.
9.5.6 W. L. Gore & Associates, Inc.
9.5.7 Teleflex Incorporated
9.5.8 Merit Medical Systems, Inc.
9.5.9 Avinger, Inc.
9.5.10 Vascular Solutions, Inc. (now part of Teleflex)
9.5.11 Biomerics, LLC
9.5.12 Cook Medical Incorporated
9.5.13 Koninklijke Philips N.V. (Philips Healthcare)
9.5.14 Stryker Corporation
9.5.15 B. Braun Melsungen AG

10. Global Vascular Closure Device Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Government procurement policies
10.1.2 Budget allocation for healthcare
10.1.3 Decision-making processes

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in healthcare infrastructure
10.2.2 Spending on medical devices
10.2.3 Trends in corporate healthcare spending

10.3 Pain Point Analysis by End-User Category

10.3.1 Challenges faced by hospitals
10.3.2 Issues in outpatient settings
10.3.3 Needs of specialty clinics

10.4 User Readiness for Adoption

10.4.1 Training and education requirements
10.4.2 Technology acceptance levels
10.4.3 Infrastructure readiness

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Expansion into new use cases
10.5.3 Long-term benefits analysis

11. Global Vascular Closure Device Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market gaps identification

1.2 Business model development


2. Marketing and Positioning Recommendations

2.1 Branding strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban retail vs rural NGO tie-ups


4. Channel & Pricing Gaps

4.1 Underserved routes

4.2 Pricing bands


5. Unmet Demand & Latent Needs

5.1 Category gaps

5.2 Consumer segments


6. Customer Relationship

6.1 Loyalty programs

6.2 After-sales service


7. Value Proposition

7.1 Sustainability

7.2 Integrated supply chains


8. Key Activities

8.1 Regulatory compliance

8.2 Branding

8.3 Distribution setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product mix
9.1.2 Pricing band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target countries
9.2.2 Compliance roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven analysis

13.2 Long-term sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone planning
15.2.2 Activity tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from medical device associations and healthcare market research firms
  • Review of published articles in peer-reviewed journals focusing on vascular closure technologies
  • Examination of regulatory filings and guidelines from health authorities such as the FDA and EMA

Primary Research

  • Interviews with cardiologists and vascular surgeons to understand device usage and preferences
  • Surveys with hospital procurement managers regarding purchasing decisions and budget allocations
  • Field interviews with medical device sales representatives to gather insights on market dynamics

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including sales data and clinical studies
  • Triangulation of insights from primary interviews with secondary data trends
  • Sanity checks conducted through expert panel discussions with industry veterans

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on global healthcare expenditure and surgical procedure volumes
  • Segmentation of the market by device type, application, and geographical region
  • Incorporation of growth rates from emerging markets and technological advancements

Bottom-up Modeling

  • Collection of sales data from leading vascular closure device manufacturers
  • Estimation of market share based on unit sales and pricing strategies
  • Volume x price analysis to derive revenue projections for each segment

Forecasting & Scenario Analysis

  • Multi-variable forecasting using historical growth rates and market trends
  • Scenario analysis based on potential regulatory changes and healthcare reforms
  • Development of baseline, optimistic, and pessimistic forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Cardiovascular Surgery Departments100Cardiologists, Surgical Team Leaders
Hospital Procurement Units60Procurement Managers, Supply Chain Directors
Medical Device Distributors50Sales Representatives, Distribution Managers
Clinical Research Organizations40Clinical Research Coordinators, Regulatory Affairs Specialists
Healthcare Policy Makers40Health Economists, Policy Analysts

Frequently Asked Questions

What is the current value of the Global Vascular Closure Device Market?

The Global Vascular Closure Device Market is valued at approximately USD 1.6 billion, driven by the increasing prevalence of cardiovascular diseases and advancements in minimally invasive surgical techniques.

What factors are driving the growth of the vascular closure device market?

Which regions dominate the Global Vascular Closure Device Market?

What are the main types of vascular closure devices available?

Other Regional/Country Reports

Indonesia Global Vascular Closure Device Market

Malaysia Global Vascular Closure Device Market

KSA Global Vascular Closure Device Market

APAC Global Vascular Closure Device Market

SEA Global Vascular Closure Device Market

Vietnam Global Vascular Closure Device Market

Other Adjacent Reports

Mexico Interventional Cardiology Devices Market

Indonesia Cardiovascular Catheters Market

Vietnam Hemostasis Devices Market

Singapore Minimally Invasive Surgery Devices Market

KSA Endovascular Devices Market

South Africa Angiography Equipment Market

Qatar cardiac surgery instruments market size, share, growth drivers, trends, opportunities & forecast 2025–2030

Belgium Wound Closure Products Market

South Korea Medical Sealants Market

Malaysia Diagnostic Imaging Systems Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022